retatrutide 2 week results 🚨 Today, retatrutide, the GIP/GLP-1/glucagon triple agonist, just delivered TRIUMPH-2 top-line results. A study in those with concurrent obesity and type diabetes. 📊 Mean body weight change at 80 weeks: ⬇️ Results of a new medication,

This helps your body adjust, so full effects may not be noticeable until your second month

Both publish their own figures and revise them over time, so compare each brand's current pricing page directly before deciding which model suits your budget

Trusted by Our Customers Our commitment to quality and customer satisfaction has earned us thousands of 5-star reviews

Improvements in visceral adiposity exceeded those observed in the comparator group receiving a sodium-glucose cotransporter 2 (SGLT2) inhibitor

In rough trial comparisons, Retatrutides TRIUMPH-1 data shows around 28.3% mean weight loss at 80 weeks on the 12 mg dose, with up to 30.3% at 104 weeks in a select extension population

Secondary Benefits These medications offer potential benefits beyond weight loss as well